Table 1.

Baseline Characteristics and Outcomes of Germinoma Patients (n = 418)

Variables		Number	%
Sex	Male	320	76.6
	Female	98	23.4
Age at diagnosis (years)	Median (min–max)	14.4 (3.8–39.1)
Location	Suprasellar	142	34
	Pineal	130	31.1
	Bifocal	69	16.5
	Basal ganglia	53	12.7
	Other (thalamus, etc.)	24	5.7
M stage	M0	334	79.9
	M+	84	20.1
Operation type	No surgery	100	23.9
	Biopsy	249	59.6
	Tumor removal (+biopsy)	69	16.5
Chemotherapy	Yes	260	62.2
	No	158	37.8
Second malignancy	No	414	99
	Yes	4	1
Serum βHCG (mIU/mL)	Median (min–max)	1.2 (0.0–712.0)
	<10	336	87.6
	≥10	50	12.0
	<50	366	87.6
	≥50	20	4.8
	Missing	32	7.7
Serum AFP (ng/mL)	Median (min–max)	1.5 (0.0–1090.0)
	Missing	28	6.7
F/U time (years)	Median (min–max)	8.9 (0.5–25.1)
Recurrence	No	368	88
	Yes	50	12
Survival	Alive	400	95.7
	Death	18	4.3

Abbreviations: M, metastasis; HCG, human chorionic gonadotropin; AFP, alpha-fetoprotein; F/u, follow-up.